J&J falls despite a beat-and-raise quarter. Why we’re raising our price target anyways
Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to its full-year guidance....
HEALTH & FITNESS
Biotech’s recovery isn’t a ‘head fake.’ These 3 stocks could lead the next leg up
The stock market's attention has been focused almost exclusively on artificial intelligence, semiconductors and a handful of megacap technology companies....
AstraZeneca’s trial flop raises bigger questions around its pipeline
AstraZeneca's failed late-stage trial for Wainua was never expected to have a major financial impact on the company.Most analysts estimate...
Abivax $920 million cash haul lets it prepare for U.S. launch: CEO
Abivax's latest funding round allows the biotech to move toward a U.S. launch of its bowel disease drug without backing...
Employers aren’t expanding coverage of GLP-1 obesity drugs: survey
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to...
Jim Cramer says these are the 5 stocks to buy during this market rotation
CNBC's Jim Cramer said Monday that investors shouldn't fear the latest market rotation. Instead, he thinks it's creating buying opportunities...
Experts say USAID closure made virus harder to contain
Doctors Without Borders health workers wearing personal protective equipment move through the isolated red zone to monitor patients, provide medical...
Jim Cramer says this former Covid market darling is finally investable again
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty...
Walmart, CVS step in to help seniors
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to...
Cramer says this stock is significantly undervalued, sees 35% upside
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...
FDA allows Philip Morris-owned Zyn marketed as less harmful cigarettes
In this photo illustration, Zyn nicotine cases are seen on a table on Jan. 29, 2024, in New York City.Michael...
Eli Lilly, Regeneron in FDA PreCheck manufacturing program
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot...
Chan Zuckerberg Biohub to open new rare disease funding round
Priscilla Chan (R) and her husband Mark Zuckerberg announce the Chan Zuckerberg Initiative to "cure, prevent or manage all disease"...
This life sciences stock has a secret weapon, and AI will only make it more valuable
IQVIA, with its vast trove of health information, sits at the center of drug development, providing data, tools and services...
Red alerts issued in UK, France, Spain and Italy
An empty street in Toulouse, France, on June 22, 2026. France experiences its second heatwave of the year, with temperatures...
UPS to invest $48 million in cold facilities amid GLP-1 boom
United Parcel Service (UPS) trucks are parked at a UPS drop yard on Oct. 28, 2025 in Vernon, California.Mario Tama...
U.S. opens tariff probe targeting Germany’s drug pricing policies
The U.S. has launched an investigation into Germany's pharma policies over what it referred to as "persistent underpayment" for medicines...
Huntington’s disease drugmaker UniQure to seek FDA OK for gene therapy
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesUniQure plans to seek FDA approval of its experimental gene therapy...
Biotech IPO window is open but big pharma M&A sets the pace: Bankers
Public markets are beginning to reopen for biotech companies after several years of muted activity. But the strongest companies may...
CVS Health executives on reducing healthcare’s biggest pain points
Nikolas Kokovlis | Nurphoto | Getty ImagesA version of this article first appeared in CNBC's Healthy Returns newsletter, which brings...
